[1]
“Expression and Clinical Relevance of p53 and BCL-2 in Bladder Cancer”, Вопр. онкол., vol. 72, no. 1, p. OF-2392, Mar. 2026, doi: 10.37469/0507-3758-2026-72-1-OF-2392.